|
Home
Search
Study Topics
Glossary
|
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
![]() |
||||||||||||||||||||||||||||||||||||
| Sponsors and Collaborators: |
New York University School of Medicine Hope Foundation |
|---|---|
| Information provided by: | New York University School of Medicine |
| ClinicalTrials.gov Identifier: | NCT00587301 |
Purpose
This study is to demonstrate the safety and efficacy of the use of the LAP-BAND surgery in the morbidly obese adolescent population.
| Condition | Intervention | Phase |
|---|---|---|
|
Obesity Adolescents DM |
Device: Lap-Band |
Phase II Phase III |
| Study Type: | Interventional |
| Study Design: | Treatment, Non-Randomized, Open Label, Uncontrolled, Single Group Assignment, Safety/Efficacy Study |
| Official Title: | A Prospective, Open-Label Study to Evaluate the Safety and Efficacy of Lap-Band® Adjustable Gastric Band (LAGB®) Operations in the Treatment of Morbidly Obese Adolescents (Ages 14-17) |
| Enrollment: | 50 |
| Study Start Date: | June 2005 |
| Estimated Primary Completion Date: | December 2012 (Final data collection date for primary outcome measure) |
| Arms | Assigned Interventions |
|---|---|
|
Lap-Band: Active Comparator
Lap-band surgery in treatment of morbidly obese adolescents
|
Device: Lap-Band
Obesity and adolescents
|
STUDY OBJECTIVES: Is to demonstrate the safety and efficacy of the use of the LAP-BAND® System in the morbidly obese adolescent population in the United States, and therefore provide these individuals with a significantly less morbid and reversible surgical option for weight loss.
STUDY VARIABLES:The primary efficacy variable is weight loss evaluated in terms of % excess weight loss (EWL).
DESIGN:Prospective, open-label, and single center
Eligibility| Ages Eligible for Study: | 14 Years to 17 Years |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Exclusion Criteria:
Contacts and Locations
More Information
| Responsible Party: | NYUSOM ( Christine Ren, M.D. ) |
| Study ID Numbers: | H# 11876, G050010 |
| Study First Received: | December 21, 2007 |
| Last Updated: | December 21, 2007 |
| ClinicalTrials.gov Identifier: | NCT00587301 History of Changes |
| Health Authority: | United States: Food and Drug Administration; NYUSOM IBRA |
|
Child Obesity |
|
Body Weight Signs and Symptoms Obesity |
Nutrition Disorders Overweight Overnutrition |
|
Body Weight Signs and Symptoms Obesity |
Nutrition Disorders Overweight Overnutrition |